|
⚲
|
| Keyboard |
| North Bridge Venture Management V LP
✚
|
|
|---|---|
| CIK # | 0001297397 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001297397] | |
| 4 | [0001297397] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyra Therapeutics Inc LYRA
Warrant to purchase Common Stock · derivative
|
2023-05-31 | Buy | 601,806 | $0.13 | 78,235 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2023-05-31 | Buy | 197,946 | $2.43 | 481,009 |
|
Lyra Therapeutics Inc LYRA
Warrant to purchase Common Stock · derivative
|
2023-05-31 | Buy | 98,973 | $0.13 | 12,866 |
|
Lyra Therapeutics Inc LYRA
Warrant to purchase Common Stock · derivative
|
2023-05-31 | Buy | 201,929 | $0.13 | 26,251 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2023-05-31 | Buy | 403,858 | $2.43 | 981,375 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2023-05-31 | Buy | 1,203,612 | $2.43 | 2,924,777 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2022-04-12 | Buy | 765,010 | $4.22 | 3,228,342 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2022-04-12 | Buy | 527,806 | $4.22 | 2,227,341 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2022-04-12 | Buy | 1,076,851 | $4.22 | 4,544,311 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Option exercise | 13,449 | $8.63 | 116,065 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Sell | 5,568 | $16.00 | 89,088 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Conversion | 651,453 | ||
|
Lyra Therapeutics Inc LYRA
Series C Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 2,420,729 | ||
|
Lyra Therapeutics Inc LYRA
Series C Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 1,186,496 | ||
|
Lyra Therapeutics Inc LYRA
Series C Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 1,545,953 | ||
|
Lyra Therapeutics Inc LYRA
Common Warrants · derivative
|
2020-05-05 | Option exercise | 21,060 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Series A-1/A Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 1,157,670 | ||
|
Lyra Therapeutics Inc LYRA
Series A-1/A Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 567,420 | ||
|
Lyra Therapeutics Inc LYRA
Series A-1/A Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 1,725,090 | ||
|
Lyra Therapeutics Inc LYRA
Series A-1/B Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 1,105,754 | ||
| showing 20 of 98 most recent transactions | |||||